Cargando…
Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about the benefit of these drugs is very uncertain and on the other hand, inf...
Autores principales: | Gracia-Ramos, Abraham Edgar, Cortes-Ortiz, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953956/ https://www.ncbi.nlm.nih.gov/pubmed/34141440 http://dx.doi.org/10.1093/omcr/omaa124 |
Ejemplares similares
-
Azithromycin/chloroquine/tacrolimus: Cardiac disorders: case report
Publicado: (2021) -
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
por: Mitra, Raman L., et al.
Publicado: (2020) -
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022) -
Azithromycin/chloroquine: Various toxicities following off-label treatment: 2 case reports
Publicado: (2021) -
Azithromycin/chloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)